A Pilot Study of Antioxidant Therapy in Obstructive Sleep Apnea Patients

NCT05009901 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Obstructive Sleep Apnea of Adult

Interventions

DRUG: Alpha Lipoic Acid 600 MG Oral Tablet
DRUG: Placebo

Sponsor

University of British Columbia